- Home
- CISO vs BRNS Comparison
CISO vs BRNS Comparison
Compare CISO & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- BRNS
- Stock Information
- Founded
- CISO 2015
- BRNS 2016
- Country
- CISO United States
- BRNS United Kingdom
- Employees
- CISO N/A
- BRNS N/A
- Industry
- CISO Computer Software: Prepackaged Software
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- BRNS Health Care
- Exchange
- CISO Nasdaq
- BRNS Nasdaq
- Market Cap
- CISO 31.4M
- BRNS 36.0M
- IPO Year
- CISO N/A
- BRNS 2021
- Fundamental
- Price
- CISO $1.20
- BRNS $1.00
- Analyst Decision
- CISO
- BRNS Strong Buy
- Analyst Count
- CISO 0
- BRNS 1
- Target Price
- CISO N/A
- BRNS $3.00
- AVG Volume (30 Days)
- CISO 1.0M
- BRNS 11.5K
- Earning Date
- CISO 08-13-2025
- BRNS 08-07-2025
- Dividend Yield
- CISO N/A
- BRNS N/A
- EPS Growth
- CISO N/A
- BRNS N/A
- EPS
- CISO N/A
- BRNS N/A
- Revenue
- CISO $29,887,603.00
- BRNS $14,969,000.00
- Revenue This Year
- CISO N/A
- BRNS N/A
- Revenue Next Year
- CISO N/A
- BRNS N/A
- P/E Ratio
- CISO N/A
- BRNS N/A
- Revenue Growth
- CISO N/A
- BRNS 4381.74
- 52 Week Low
- CISO $0.26
- BRNS $0.64
- 52 Week High
- CISO $3.84
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- CISO 53.82
- BRNS 53.30
- Support Level
- CISO $1.12
- BRNS $0.90
- Resistance Level
- CISO $1.25
- BRNS $0.94
- Average True Range (ATR)
- CISO 0.12
- BRNS 0.05
- MACD
- CISO -0.01
- BRNS 0.00
- Stochastic Oscillator
- CISO 57.68
- BRNS 96.80
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.